Advertisement Advertisement
The technology is invisible.
Notes
Visit us at
Booth C04 at WoCoVA
The benefits are plain to see. The BioFlo™ PICC, the first PICC to incorporate Endexo™ Technology, provides a catheter material more resistant to the accumulation of blood components (platelets and thrombus). The BioFlo PICC is the only PICC manufactured with Endexo Technology, a permanent and non-eluting integral additive present throughout the catheter material. In-vitro blood loop test results demonstrate that the BioFlo PICC with Endexo Technology accumulated 87% less thrombus on average (based on platelet counts) compared to other commonly used PICCs.* The BioFlo PICC is also available with our patented PASV™ Valve Technology designed to automatically resist backflow and reduce blood reflux on the inside of the catheter. For more information, contact your local Distributor or visit the Global Partners section of our website at www.navilystmedical.com
*Based on benchtop tests which may not be indicative of clinical results. Data on file. Images are representative samples from benchtop tests. Endexo is a trademark of Interface Biologics. BioFlo, PASV and Navilyst Medical are trademarks and/or registered trademarks of Navilyst Medical, Inc., 26 Forest Street, Marlborough, MA 01752 BIOFLO PICC WITH ENDEXO AND PASV VALVE TECHNOLOGY INTENDED USE/INDICATIONS FOR USE: The BioFlo PICC with Endexo and PASV Valve Technology is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients; the sampling of blood; and for power injection of contrast media. Refer to Directions for Use provided with the product for complete instructions. Not currently for sale in the US. Pending 510(k) clearance. © 2012 Navilyst Medical, Inc., or its affiliates. All rights reserved. NAVAD420 / 04/12
Page 65